ACH Share Price Performance
US$1.96
-7.31 (-78.86%)
39.7% undervalued intrinsic discount
US$3.25
Fair Value
Price US$1.96
AnalystConsensusTarget US$3.25
AnalystHighTarget US$7.00
AnalystLowTarget US$2.25
Fair ValueUS$3.25
Share Pricen/a
Accendra Health, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 9 Fair Values set on narratives written by author
ACH Community Narratives
AN
Fair Value US$3.25 39.7% undervalued intrinsic discount
Patient Direct Model Will Transform Home-Based Health Care Market
0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
Fair Value US$7 72.0% undervalued intrinsic discount
Home-based Care Expansion Will Drive Secular Growth
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$2.25 12.9% undervalued intrinsic discount
Rising Healthcare Pressures Will Exacerbate Patient Direct Vulnerabilities
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
Rising Healthcare Pressures Will Exacerbate Patient Direct Vulnerabilities
Key Takeaways Narrow operational focus and rising competition heighten revenue unpredictability and vulnerability to industry shifts that bypass traditional distributors. Persistent debt burden, margin pressures, and cost volatility limit financial flexibility and threaten sustainable earnings growth.Read more
33
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
US$2.25
12.9% undervalued intrinsic discount
Fair Value
Profit Margin
5.16%
Future PE
1.73x
Price in 2029
US$3.15
Patient Direct Model Will Transform Home-Based Health Care Market
Key Takeaways Focusing on higher-margin home-based care and divesting lower-growth segments enhances long-term growth, margin expansion, and free cash flow. Investments in technology, operational efficiency, and targeted acquisitions improve profitability and support ongoing balance sheet strengthening.Read more
83
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
5users have followed this narrative
AN
US$3.25
39.7% undervalued intrinsic discount
Fair Value
Profit Margin
5.47%
Future PE
2.21x
Price in 2029
US$4.55
Home-based Care Expansion Will Drive Secular Growth
Key Takeaways Leadership in home-based care and high-growth medical categories positions Owens & Minor for strong, recurring revenue and margin gains. Investments in automation, IT, and focused M&A enhance operating leverage, supporting faster cash flow growth and increased long-term contract wins.Read more
18
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$7
72.0% undervalued intrinsic discount
Fair Value
Profit Margin
0.46%
Future PE
78.74x
Price in 2028
US$9.79
Trending Discussion
Recently Updated Narratives
AN
ACH: Share Repurchases And New Identity Will Support Future Upside
Fair Value: US$2.25 12.9% undervalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
ACH: Rebranding And 2026 Outlook Will Support Improved Profitability Narrative
Fair Value: US$3.25 39.7% undervalued intrinsic discount
5 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Home-based Care Expansion Will Drive Secular Growth
Fair Value: US$7 72.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Accendra Health, Inc. Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -1.34
- 46.68%
- -3.72%
- -444.7%
About ACH
- Founded
- 1882
- Employees
- 6500
- CEO
- WebsiteView website
Accendra Health, Inc., together with its subsidiaries, operates as a healthcare solutions company in the United States. It offers a range of products and services for in-home care and delivery for diabetes treatment; home respiratory therapy, including home oxygen and non-invasive ventilation services; obstructive sleep apnea treatment, such as continuous positive airway pressure and bi-level positive airway pressure devices, and patient support services. The company also supplies other home medical equipment, patient care product lines including ostomy, wound care and negative pressure wound therapy, urology, incontinence, and other products and services. It serves patients and home health agencies. The company was formerly known as Owens & Minor, Inc. and changed its name to Accendra Health, Inc. in December 2025. Accendra Health, Inc. was founded in 1882 and is based in Glen Allen, Virginia.
